'Mild risk' prompts Ontario to recommend Pfizer over Moderna for those aged 18-24

An increase in cases of a rare heart condition in young adults who have received the COVID-19 Moderna vaccines has prompted Ontario to recommend the Pfizer-BioNTech shots for those aged 18 to 24 "out of an abundance of caution."